Australian researchers have discovered new biomarkers that they say can increase the accuracy of determining the aggressiveness of prostate cancer in about 40 per cent of cases.
The findings led to a laboratory test that was launched in the US earlier this month, but is not available in Australia yet.
Loading...
Jill Margo is based in the Sydney office. Jill has won multiple prizes, including two Walkley Awards and is an adjunct associate professor at School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia. Connect with Jill on Twitter. Email Jill at jmargo@afr.com
